Experimental study on the prevention of vasospasm following subarachnoid hemorrhage by a thromboxane A2 synthetase inhibitor, OKY-046
Ohsugi, S.
Nihon Geka Hokan. Archiv für Japanische Chirurgie 55(2): 297-305
1986
ISSN/ISBN: 0003-9152 PMID: 3827476 Document Number: 269836
Document emailed within 1 workday
Related Documents
Niizuma, H.; Kwak, R.; Ohi, T.; Katakura, R.; Mizoi, K.; Suzuki, J. 1978: The angiographical study on cerebral vasospasm following the rupture of intracranial aneurysm (1st report).--Time relationship between vasospasm on angiography and the onset of subarachnoid hemorrhage (aurhor's transl) No Shinkei Geka. Neurological Surgery 6(8): 749-755Yanaka, K.; Kamezaki, T.; Fujita, K.; Kato, N.; Nagase, S.; Hirayama, A.; Asakawa, H.; Yamazaki, T.; Nose, T. 2001: Prevention of delayed cerebral vasospasm after aneurysmal subarachnoid hemorrhage Drugs of Today 37(8): 573-578
Smeesters, C.; Chaland, P.; Giroux, L.; Moutquin, J.M.; Etienne, P.; Douglas, F.; Corman, J.; St-Louis, G.; Daloze, P. 1988: Prevention of acute cyclosporine A nephrotoxicity by a thromboxane synthetase inhibitor Transplantation Proceedings 20(2 Suppl. 2): 663-669
Nishizawa, Y. 1993: The pathogenesis and the preventive treatment of cerebral vasospasm following subarachnoid hemorrhage--especially clinical and pharmacological effect of Ca++ antagonist for vasospasm Nihon Rinsho. Japanese Journal of Clinical Medicine 51 Suppl: 389-396
Nakayama, D.; Ikeda, T. 1988: Effect of OKY-046, a thromboxane synthetase inhibitor, on renal thromboxane synthesis in spontaneously hypertensive rat Nihon Jinzo Gakkai Shi 30(1): 79-84
Chiabrando, C.; Broggini, M.; Castelli, M.G.; Cozzi, E.; Castagnoli, M.N.; Donelli, M.G.; Garattini, S.; Giavazzi, R.; Fanelli, R. 1987: Prostaglandin and thromboxane synthesis by M5076 ovarian reticulosarcoma during growth: effects of a thromboxane synthetase inhibitor Cancer Research 47(4): 988-991
Majchrzak, H.; Lech, A.; Kopera, M.; Gajos, L.; Dragan, T.; Ladziński, P. 1995: Application of alteplase in prevention of cerebral vasospasm and its sequelae in patients after aneurysmal subarachnoid hemorrhage from ruptured cerebral aneurysm Neurologia i Neurochirurgia Polska 29(3): 379-387
Murayama, K.; Kasai, H.; Adachi, T.; Utsunomiya, O.; Ouchi, H. 1983: Comparative study of prostaglandin I2 (PG I2) and thromboxane A2 (TXA2) synthetase inhibitor (OKY-1581) on hemodynamics in pregnant dogs Nihon Sanka Fujinka Gakkai Zasshi 35(3): 344-350
Sills, T.; Heptinstall, S. 1986: Effects of a thromboxane synthetase inhibitor and a cAMP phosphodiesterase inhibitor, singly and in combination, on platelet behaviour Thrombosis and Haemostasis 55(3): 305-308
Desbordes, J.M.; Ades, P.E.; Guggiari, M. 1989: Intravenous nimodipine in the treatment of cerebral vasospasm following subarachnoid hemorrhage caused by aneurysm rupture: a comparative multicenter study Agressologie: Revue Internationale de Physio-Biologie et de Pharmacologie Appliquees Aux Effets de l'Agression 30(7): 438-440
Basevich, V.V.; Mevkh, A.T.; Varfolomeev, S.D. 1984: Kinetic mechanisms of enzyme activity of the thromboxane synthetase system. Thromboxane synthetase of human platelets Biokhimiia 49(9): 1538-1545
Machida, K.; Takagi, K.; Horiba, M. 1996: Thromboxane A2 synthetase inhibitor in asthma therapy Nihon Rinsho. Japanese Journal of Clinical Medicine 54(11): 3034-3039
Stachura, K.; Danilewicz, B.; Kamieniecka, B. 1996: Significance of CT in the assessment of risk due to cerebral vasospasm following subarachnoid hemorrhage Neurologia i Neurochirurgia Polska 30(4): 609-616
Nakayama, K.; Obara, K.; Tanabe, Y.; Ishikawa, T.; Nishizawa, S.; Koide, M. 2003: Mechanical stress and cerebrovascular response--resemblance to cerebral vasospasm after subarachnoid hemorrhage Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica 122 Suppl: 33p-36p
Bastianello, S.; Bozzao, A.; Pierallini, A.; Giannini, A. 1986: Neuroradiologic diagnostic possibilities of "symptomatic" vasospasm in subarachnoid hemorrhage. Case report Minerva Psichiatrica 27(4): 341-344
Kawano, T.; Yonekawa, Y. 1990: Serum complements as indicator for predicting vasospasm and its severity after aneurysmal subarachnoid hemorrhage Nihon Geka Hokan. Archiv für Japanische Chirurgie 59(3): 189-197
Okamoto, S.; Yonekawa, Y.; Handa, H.; Handa, Y.; Uemura, Y.; Yano, I.; Toyoshima, M.; Iwatsuji, K.; Teraura, T.; Yamagata, S. 1986: Treatment of occlusive cerebrovascular disease with a selective thromboxane A2 synthetase inhibitor Nihon Geka Hokan. Archiv für Japanische Chirurgie 55(1): 251-259
Grauer, G.F.; Frisbie, D.D.; Longhofer, S.L.; Cooley, A.J. 1992: Effects of a thromboxane synthetase inhibitor on established immune complex glomerulonephritis in dogs American Journal of Veterinary Research 53(5): 808-813
Fomsgaard, J.S.; Kim, Y.D.; Burke, T.A.; Viswanathan, T.; Schaffer, A.V.; Peppard, J.; Douglas, F.L.; Danchak, M.; Myers, A.K. 1992: Comparison of thromboxane synthetase inhibitor and methylprednisolone effects on protamine responses in dogs Anesthesia and Analgesia 74(1): 38-43
Niwa, T.; Maeda, K.; Shibata, M.; Yamada, K. 1988: Clinical effects of selective thromboxane A2 synthetase inhibitor in patients with nephrotic syndrome Clinical Nephrology 30(5): 276-281